Quarterly Report for Quarter Ending November 30, 2024 (Form 10-Q)
FDA Accepts Agios’ Supplemental New Drug Application for PYRUKYND®[...]
Sage Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare[...]
01/07/2025 | Press release | Distributed by Public on 01/07/2025 06:05
Please select the service you want to use:
Smartlinks | OraSure Technologies Inc. | News | Health | HIV/AIDS | Science | Research | HIV/AIDS | Politics and Policy | Policy and Regulation | Company News | Business Announcement | Products and Services | Corporate Litigation and Regulation | Securities Issuers | Medical Supplies and Equipment Companies | Frankfurt Stock Exchange | Dusseldorf Stock Exchange | Munich Stock Exchange | Stuttgart Stock Exchange | BX Swiss | Tradegate Exchange | NYSE American | NYSE ARCA Equities | Nasdaq Global Select Market | Cboe BZX Exchange | Cboe Off Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | NYSE National | FINRA Alternative Display Facility (ADF) | Saint Petersburg Exchange (SPB) | Nasdaq BX | Nasdaq PSX | NYSE Chicago
Back
Copyright ©2006-2025 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact